House Appropriations Subcommittee Plans FDA Hearing July 26
This article was originally published in The Pink Sheet Daily
Ag/FDA subcommittee had tabled FDA hearing pending confirmation of a permanent agency commissioner. House cleared FDA 2006 spending in early June.
You may also be interested in...
Amgen, J&J, Sanofi-Aventis, Pfizer, Merck, Roche, Lilly and Schering-Plough are scheduled to report results in upcoming week. Bristol could expand upon plans to sell OTC unit to Novartis the following week.
Homeland Security/Emergency Preparedness Subcommittee and Government Reform Committee hearings will focus on countermeasure procurement issues and evaluating the effectiveness of the BioShield Act of 2004.
CDER officials Jenkins, Holquist and Abrams are among the FDA panelists at three-day IoM committee meeting. Senate Finance and Health Committees staff directors and industry reps also are on the agenda.